Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Thalidomide + Dexamethasone in Newly Diagnosed ITP
NCT01976195Phase 2Withdrawn
- Sponsor
- Shandong University
- Start
- Oct 2013
- Primary completion
- Dec 2014
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 2 trial of thalidomide in immune thrombocytopenia (ITP), sponsored by Shandong University. Planned start Oct 2013; status: withdrawn.
02
Drugs
thalidomide
03
Conditions
immune thrombocytopenia (ITP)
Beyond the preview
Go deeper on NCT01976195.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT01976195.